The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Antisedan 5 mg/ml solution for injection

Orion CorporationVPA10664/003/001

Main Information

Trade NameAntisedan 5 mg/ml solution for injection
Active SubstancesAtipamezole hydrochloride
Dosage FormSolution for injection
Licence HolderOrion Corporation
License Holder AddressOrionintie 1
FI-02200 Espoo
Licence NumberVPA10664/003/001

Group Information

ATC CodeQV03AB90 atipamezole
Therapeutic ClassNeurological Preparations


License statusAuthorised
Licence Issued26/02/2010
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back